FoxP3+ Treg infiltration in both compartments was also evaluated according to patient clinical data, such as gender, tumor localization, tumor stage, tumor histological grade, tumor invasion and tumor risk factors (Table 1). This evidence concerns the gene FOXP3 and neoplasm.